Back to Search
Start Over
Supplemental Figure S3 from Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- MET tyrosine kinase domain modeling location of the F1200 residue
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....17adb0a2f01ca02b6f8212336e945b74